Am I a good candidate for an implanted venous access device?

 

Q: Am I a good candidate for an implanted venous access device? 

A: A venous access device, or VAD, is a catheter or port that is surgically placed in your body to give access to a major vein. These devices are often used with patients who are receiving long-term chemotherapy, chemotherapy that is infused by a portable pump over days, frequent blood tests, transfusions, or other treatment-related care. Some patients on chemotherapy receive VAD implants, others don't.

Whether you will have a VAD depends upon your treatment plan, the physical condition of your veins, and other factors your doctor will consider. While you're in treatment, your VAD will need to be flushed after each session to keep it from becoming clogged. After treatment ends, you'll need to have it flushed every 4 to 6 weeks.
--Bernice Crook, RN, OCN

Cancer patients have greater risk of blood clots, but can watch for danger signals.

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health